Bandingkan Harga & Kinerja Kokoh Exa Nusantara Tbk (KOCI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Kokoh Exa Nusantara Tbk dan Organon Pharma Indonesia Tbk.: Kokoh Exa Nusantara Tbk diperdagangkan di Rp134 (kapitalisasi pasar 576,31 M, volume 24 jam 60,42 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Kokoh Exa Nusantara Tbk jauh lebih besar — sekitar 5,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| KOCI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 576,31 M | 104,4 M |
Volume | 60,42 jt | — |
Lot | 604,22 rb | — |
Perputaran | 7,95 M | — |
Harga Rata-rata | 131,63 | — |
Nilai Transaksi | 7,95 M | — |
Harga Ekuilibrium Indikatif | 134 | — |
Volume Ekuilibrium Indikatif | 5,59 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Kokoh Exa Nusantara Tbk
PT Kokoh Exa Nusantara Tbk (the Entity) was established based on Notarial Deed No. 173, dated July 31, 2019 of Dwi Rossulliati, S.H., notary in Mojokerto Regency. The Entity started its commercial operations in 2020. PT Exa Nusa Persada is its ultimate parent entity.
Selengkapnya di halaman KOCI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
